Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport

This publication has 103 references indexed in Scilit:

• Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
• Endothelial Lipase Concentrations Are Increased in Metabolic Syndrome and Associated with Coronary Atherosclerosis
  PLoS Medicine, 2005
• Liver X Receptor Activation Controls Intracellular Cholesterol Trafficking and Esterification in Human Macrophages
  Circulation Research, 2005
• Effectiveness of Inhibition of Cholesteryl Ester Transfer Protein by JTT-705 in Combination With Pravastatin in Type II Dyslipidemia
  The American Journal of Cardiology, 2005
• Cholesteryl Ester Transfer Protein and Coronary Artery Disease
  Circulation, 2004
• Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study
  American Heart Journal, 2004
• Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease
  Drugs, 2004
• Dose-Dependent Acceleration of High-Density Lipoprotein Catabolism by Endothelial Lipase
  Circulation, 2003
• PPARs as Therapeutic Targets: Reverse Cardiology?
  Science, 2003
• Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2003